Nuvation Bio (NUVB) Current Assets (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Current Assets of $591.5 million for Q1 2026, up 24.38% year-over-year from $475.6 million in Q1 2025, and up 3.5% quarter-over-quarter from $571.5 million in Q4 2025.
Nuvation Bio (NUVB) Current Assets (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Current Assets for 7 consecutive years, with $591.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 24.38% year-over-year to $591.5 million; the TTM figure through Mar 2026 stood at $591.5 million (up 24.38% YoY), while the FY2025 annual figure was $571.5 million, up 8.6% from the prior year.
- Current Assets improved to $591.5 million in Q1 2026 per NUVB's latest filing, from $571.5 million in the prior quarter.
- Across five years, Current Assets topped out at $748.0 million in Q1 2022 and bottomed at $475.6 million in Q1 2025.
- Historically, Current Assets has averaged $615.8 million across 5 years, with a median of $616.4 million in 2023.
- Annual changes were most pronounced in 2025 — Current Assets decreased 21.79% — and 2026, when it advanced 24.38%.
- Nuvation Bio's Current Assets stood at $667.3 million in 2022, then retreated by 7.63% to $616.4 million in 2023, then slipped by 14.63% to $526.3 million in 2024, then advanced by 8.6% to $571.5 million in 2025, then grew by 3.5% to $591.5 million in 2026.
- Business Quant data shows NUVB's Current Assets at $591.5 million in Q1 2026, $571.5 million in Q4 2025, and $577.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 726.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 726.43 Mn |
| Mar 31, 2026 | 591.53 Mn |
| Dec 31, 2025 | 571.52 Mn |
| Sep 30, 2025 | 577.53 Mn |
| Jun 30, 2025 | 623.21 Mn |
| Mar 31, 2025 | 475.57 Mn |
| Dec 31, 2024 | 526.26 Mn |
| Sep 30, 2024 | 564.99 Mn |
| Jun 30, 2024 | 587.17 Mn |
| Mar 31, 2024 | 608.06 Mn |
| Dec 31, 2023 | 616.43 Mn |
| Sep 30, 2023 | 625.35 Mn |
| Jun 30, 2023 | 637.23 Mn |
| Mar 31, 2023 | 652.56 Mn |
| Dec 31, 2022 | 667.32 Mn |
| Sep 30, 2022 | 681.39 Mn |
| Jun 30, 2022 | 714.26 Mn |
| Mar 31, 2022 | 748.04 Mn |
| Dec 31, 2021 | 772.07 Mn |
| Sep 30, 2021 | 796.61 Mn |